Exact Sciences Corporation

EXASNASDAQHealthcare

$104.91

+$0.00(+0.00%)

Market Cap$20.0B

P/E Ratio—

52W High$104.98

52W Low$38.81

Avg Volume2.5M

Open$104.91

Beta1.44

Free Cash Flow Financials Revenue

Exact Sciences Corporation (EXAS) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

EXAS · free cash flow · updated Jun 8, 2026

Core FCF metrics

EXAS · FCF · TTM · margin & CAGR

Free cash flow was $356.8M for FY2025 (fiscal year ending 2025-12-31), up 378.6% year-over-year The FCF margin was 11.0%. Five-year CAGR stands at +37.7%.

FY2025 Free Cash Flow$356.8M▲ +378.6% YoY

Trailing 12M (TTM)$356.8Mtrailing 4 quarters sum

FCF Margin11.0%$356.8M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGR+37.7%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

EXAS · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$491.4M(135M)$356.8M▲ +378.6%11.0%

FY2024$210.5M(136M)$74.5M▲ +133.5%2.7%

FY2023$156.1M(124M)$31.9M▲ +107.3%1.3%

FY2022−$223.6M(214M)−$438.0M▼ 84.0%-21.0%

FY2021−$102.2M(136M)−$238.0M▼ 430.0%-13.5%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

EXAS · P/FCF · FCF yield · FCF per share

Exact Sciences Corporation (EXAS) trades at a FCF yield of 1.78% and a price-to-free-cash-flow ratio of 55.5x. FCF per share stands at $1.89, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

1.78%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$1.89

TTM FCF ÷ Shares Outstanding

Price / FCF

x55.5

Share Price ÷ FCF per Share

EV / FCF (TTM)

x60.5

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

EXAS · cash flow statement · operating / investing / financing

For FY2025, Exact Sciences Corporation generated $491.4M in operating cash flow and spent 135M in capital expenditures, yielding $356.8M in free cash flow.

Operating Activities

+$491.4M

Cash from core business operations

2025-12-31

Investing Activities

+$195.1M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$338.1M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($491.4M) − |CapEx| (135M) = FCF ($356.8M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

EXAS vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Exact Sciences CorporationYOU

EXAS

$356.8M+378.6%11.0%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Exact Sciences Corporation (EXAS) reported free cash flow of $356.8M for FY2025 (fiscal year ending 2025-12-31), up 378.6% year-over-year. The FCF margin was 11.0%.

Based on available data, Exact Sciences Corporation has maintained positive free cash flow for at least 4 fiscal year(s). FCF peaked at $356.8M in FY2025. The 5-year CAGR stands at +37.7%.

Exact Sciences Corporation's FCF yield is 1.78% and price-to-FCF ratio is 55.5x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

EXAS free cash flow · 8 questions

Exact Sciences Corporation free cash flow was $356.8M for FY2025, up 378.6% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $356.8M.

EXAS free cash flowEXAS FCFEXAS FCF 2025EXAS free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Exact Sciences Corporation · Exact Sciences Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026